Overview
Non-interventional observational study, to identify safety and effectiveness of Somavert during the post-marketing period based on the Korean RMP as required by the regulations of Ministry of Food and Drug Safety (MFDS)
Eligibility
Inclusion Criteria:
All patients who have been prescribed as per local label and investigators' judgement under the setting of routine practice in Korea who are eligible.
Exclusion Criteria:
Patients who are contraindicated for Somavert